Diligence memo · auto-generated · as of July 2, 2026
Omnilytics Inc
Omnilytics Inc looks fair against its niche peers and is dormant on financing cadence.
Businessfiled
Omnilytics Inc operates in Biotechnology, based in Sandy.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Omnilytics Inc has raised $700K in disclosed capital across 2 recorded rounds, aggregated from public filings. Its latest round is modeled as Pre-Seed (a round under $1.0M).
Largest single filing: $500K on 2010-11-17.
Most recent recorded round closed around 2013-06-27.
Valuation (modeled)modeled
Provath models Omnilytics Inc at approximately $11M (range $107K–$125M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Fair. Modeled value is 0.70× the median modeled value of Pre-Seed Biotechnology companies in 2013–2015 (131 peers) — value vs value, same stage and era. Within the normal band (70% of peer median) for its niche.
Financing rhythm & timingmixed
Historic cadence: a new round about every 31 months.
Last raise 13.0 yr ago; this sector typically re-raises about every 14 months.
Silent for over 3× the sector's normal cadence.
The last round was 2.5× smaller than the prior — a bridge or down round.
Comparablesmixed
Capital scale ranks ahead of 14% of Biotechnology peers (4293 compared).
Modeled value ranks above 20% of those peers.
Closest niche peers: Imanis Life Sciences, LLC, Truminim, LLC, Direct Spinal Therapeutics, Inc., Universal Biosensors Inc, One World Lab, Inc..
Peoplefiled
7 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.